When using genetically corrected DMD iPSC-derived CD271+ cells, the cells showed better engraftment in the muscle of dystrophin-deficient NSG mice compared to CD56+ cells (Hicks et al., 2017). The gene discussed is NGFR; the disease is Duchenne muscular dystrophy.